-+ 0.00%
-+ 0.00%
-+ 0.00%

What Celsius Doubters Saw Before The Drop

Simply Wall St·11/06/2026 00:33:12
Listen to the news

If you had backed Celsius on 1 January 2026 expecting expanding distribution, health-focused branding and analyst targets to carry the story, the outcome would have hurt. Holding Celsius from the start of the year would have meant a 37.1% loss, including dividends. If that decision felt grounded in 30.1% revenue growth forecasts, margin expansion to 14.5% and a future P/E of 47.7x, what exactly did those assumptions miss about product risk, regulation and execution?

If the move has made Celsius harder to judge, start where the gap is still open and scan 42 high quality undervalued stocks.

The Two Celsius Stories Investors Had To Weigh

The shares cost US$45.74 at the start, and Celsius sat between two sharply different stories that both sounded reasonable on the numbers.

On the optimistic side, one camp argued that wider distribution and board access could justify a Fair Value of US$66.28, essentially a price implied by assumptions of 30.1% revenue growth and profit margins reaching 14.5% within three years.

The cautious view pointed to tightening beverage rules and supply strain, backing a Fair Value of US$33.5 and stressing regulation and supply chain fragility as the key risk to those future cash flows.

NasdaqCM:CELH Trailing 12-Month Earnings & Revenue History as at Nov 2026
NasdaqCM:CELH Trailing 12-Month Earnings & Revenue History as at Nov 2026

What The Evidence Said About Celsius Assumptions

Celsius spent 2026 juggling growth and legal heat. Q1 brought US$783 million in revenue and a 20.9% U.S. energy drink share, which helped the expansion story. Later reports showed pressure on the core CELSIUS brand, margin strain, leadership churn and multiple lawsuits tied to Alani Nu health and disclosure claims. The evidence cut both ways.

The key assumption investors can test elsewhere is that health-focused branding naturally limits regulatory and legal exposure. For any consumer stock, track product safety probes, youth marketing scrutiny and class actions alongside revenue and margin headlines.

What Celsius’s Drop Leaves You Paying For Today

Celsius trades at US$30.03, well below where it started the year, and the selected Narrative’s Fair Value now sits above that level rather than below it.

The bullish case leans on a long distribution buildout, Pepsi’s role and energy drink category breadth. A buyer today must believe the recent fall signals distribution and inventory noise resolving, not a weakening consumer franchise.

"The ones who understood what actually happened in 2024 and why the crash was a channel inventory problem, not a brand problem, had the best entry point in a decade. This narrative is about understanding which of those two situations you are looking at right now, as the company enters an entirely new chapter."

The price and this Narrative do not agree. → Uncover what this Narrative says Celsius is actually worth

Looking One Step Beyond Celsius

Celsius sits in coolers, shelves and taps that already feel crowded. You are really betting on its share within an existing habit.

That same habit also leans on a giant working quietly in the background. It channels money into drinks, snacks and the systems that move them.

Some investors look past the newest can and study that backbone instead. It tries to match modest sales progress with dependable cash distributions.

The interesting angle is how both stories rhyme. One leans on bursts of excitement, the other prefers long races where income matters.

One Narrative has already put a figure on it. → Uncover the company trading 29% below one Narrative's Fair Value